Routine evaluation of meibomian glands, starting in childhood, is crucial for identifying and managing this progressive ...
Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease (EDED) and dysfunction is widely thought to mechanistically involve ductal hyperkeratinization, plugging and ...
A new device for meibomian gland debridement was safe and effective and demonstrated time and space benefits compared with conventional debridement and expression approaches, according to a study ...
Washing your lids, taking breaks and staying hydrated can all help, according to a founder who’s taking on the issue.
Carolyn Adelsten woke up feeling like something was in her eye and it wouldn't come out. She visited an eye specialist, got a diagnosis of mild dry eye disease and was told to ...
Dry Eye Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future grow ...
Sight Sciences’ management is scheduled to present on Thursday, February 27, 2025, at 7:15 am PT / 10:15 am ET. Interested parties may access a live and archived webcast of the fireside chat on the ...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. One ...
Bleakley Financial Group LLC bought a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 5,825 shares ...
OT presents a clinical scenario to three of its resident IP optometrists. Here, a 40-year-old with dry eye disease and an adverse reaction to prescribed eye drops ...
AZR-MD-001, met its primary endpoints of showing improvements in both the signs and symptoms of dry eye disease caused by Meibomian gland dysfunction (MGD) reaching statistical significance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results